Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 153 The United Laboratories International Holdings Limited Annual Report 2019 43. RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES The table below details changes in the Group’ liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be, classified in the Group’s consolidated statement of cash flows as cash flows from financing activities. Obligations under Convertible finance Lease Dividend Borrowings bonds leases liabilities payable Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note 31) (Note 32) (Note 30) (Note 29) (Note 15) At 1 January 2018 3,469,043 1,038,223 401,233 – – 4,908,499 Financing cash flows (379,620) (35,121) (304,986) – (84,443) (804,170) Derecognition of bills receivables (24,587) – – – – (24,587) Conversion of convertible bond – (81,177) – – – (81,177) Fair value change – (226,414) – – – (226,414) Finance cost 160,480 88,648 19,748 – – 268,876 Dividend declared – – – – 84,443 84,443 Exchange loss (16,362) 46,735 – – – 30,373 At 31 December 2018 3,208,954 830,894 115,995 – – 4,155,843 Adjustment upon application of HKFRS 16 – – (115,995) 119,305 – 3,310 At 1 January 2019 3,208,954 830,894 – 119,305 – 4,159,153 Financing cash flows 574,131 (37,924) – (120,093) (98,383) 317,731 Derecognition of bills receivables (16,019) – – – – (16,019) Conversion of convertible bond – (8,337) – – – (8,337) Fair value change – 110,117 – – – 110,117 Finance cost 185,240 97,356 – 2,551 – 285,147 Dividend declared – – – – 98,383 98,383 Exchange loss 35,683 16,327 – – – 52,010 At 31 December 2019 3,987,989 1,008,433 – 1,763 – 4,998,185